©2013 Baishideng Publishing Group Co.
World J Gastrointest Pathophysiol. Feb 15, 2013; 4(1): 12-17
Published online Feb 15, 2013. doi: 10.4291/wjgp.v4.i1.12
Published online Feb 15, 2013. doi: 10.4291/wjgp.v4.i1.12
Table 1 Stage of gastric cancer n (%)
| Group tested | |
| Tumor stage | I+ II |
| (TNM classification) | 6 (14) |
| III | |
| 18 (42) | |
| IV | |
| 19 (44) | |
| T1 | |
| Depth of tumor invasion | 2 (6) |
| T2 | |
| 4 (13) | |
| T3 | |
| 15 (47) | |
| T4 | |
| 11 (34) | |
| N0 | |
| Lymph node metastases | 7 (17) |
| N1 | |
| 4 (9) | |
| N2 | |
| 13 (31) | |
| N3 | |
| 18 (43) | |
| Distant metastases | M0 |
| 9 (47) | |
| M1 | |
| 10 (53) |
- Citation: Matowicka-Karna J, Kamocki Z, Kemona H. Assessment of platelet activation and phagocytic activity in gastric cancer patients. World J Gastrointest Pathophysiol 2013; 4(1): 12-17
- URL: https://www.wjgnet.com/2150-5330/full/v4/i1/12.htm
- DOI: https://dx.doi.org/10.4291/wjgp.v4.i1.12